Download Medical Notes on EvaluatePharma Orphan Drug Report 2020

EvaluatePharma Orphan Drug Report 2020 Medical Notes

About This Presentation

Description:Ever wondered what will the orphan drug landscape look like in the year 2024? Big pharma's recent dominance of the orphan market has invited calls to amend the orphan drug act in the United States. Regardless, orphan drug sales are expected to increase from $119bn in 2018 to $217bn in 2024. Download and check this EvaluatePharma Orphan Drug Report 2020 to learn which company would lead with a 7.6% share of the total orphan market in 2024, which orphan drug would fetch $10bn in 2024, alone and what percentage of worldwide sales will pipeline orphan drugs make up in 2024.

Tags:Orphan drug, pharma, pharmaceutical, drug sales, EvaluatePharma

Published on: Jun 29, 2020 | Views : 1900 | Downloads : 1

Comment

Transcript

No transcript available for this presentation

User Presentation
Related Presentations

Value of Pharmaceuticals in Managed Care Pharmacy

About : An experienced pharma professional managing sales, marketing and brand management of top global pharma products Presently leading a team of experts in the development and execution of pharma eCommerce strategies that support GSK products to HCP customers.
Occupation : Medical Professional
Specialty : Other Health Professionals
Country : United States of America
Website :

Value of Pharmaceuticals in Managed Care Pharmacy

High-Performance Pharma Brand Plans - The 5 Pitfalls to avoid

2020 Deloitte global healthcare outlook

Generics and Biosimilars Industry Response to COVID-19

Rare Diseases and the Orphan Drug Act in the US

2020 US and global life sciences outlook

Global Medicine Spending and Usage Trends - Outlook to 2024

Anti Diarrheal Drug

Understanding Neuromuscular Disease Care Current State and Future Prospects

Taming big Pharma

HEALTH A TO Z